Evidence map›Paper›PMID 30845359›Full record

ArticleBritish journal of clinical pharmacology2019

A multiple methods approach to determine adherence with prescribed mycophenolate in children with kidney transplant.

Reham Almardini, Esra' O Taybeh, Mervat M Alsous, Ahmed F Hawwa, Karl McKeever, Rob Horne, James C McElnay

Open access · bronzeAbstract read
In one paragraph

Article in British journal of clinical pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Insights into adherence to medication and lifestyle recommendations in an international cohort of patients with catecholaminergic polymorphic ventricular tachycardia.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Reham AlmardiniDepartment of Pediatric Nephrology, King Hussien Medical Center, Amman, Jordan.
Esra' O TaybehDepartment of Applied Pharmaceutical Sciences, School of Pharmacy, Isra University, Amman, Jordan.ORCID 0000-0001-7493-7865
Mervat M AlsousDepartment of Pharmacy Practice, School of Pharmacy, Yarmouk University, Irbid, Jordan.ORCID 0000-0002-6678-670X
Ahmed F HawwaClinical and Practice Research Group, School of Pharmacy, Queen's University Belfast, Belfast, UK.ORCID 0000-0003-0547-7361
Karl McKeeverDepartment of Paediatric Nephrology, Royal Belfast Hospital for Sick Children, Belfast, UK.
Rob HorneCentre for Behavioural Medicine, UCL School of Pharmacy, University College London, London, UK.
James C McElnayClinical and Practice Research Group, School of Pharmacy, Queen's University Belfast, Belfast, UK.ORCID 0000-0002-1082-9715
Queen's University Belfast · GBKing Hussein Medical Center · JORoyal Belfast Hospital for Sick Children · GBUniversity College London · GBYarmouk University · JO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThe aim of this study was, to use a multiple methods approach, including, for the first time, dried blood spot (DBS) sampling with population pharmacokinetic interpretation, to assess adherence to mycophenolate in children with kidney transplant. A second aim was to identify patient/parental factors that influenced adherence and to link adherence behaviour to clinical outcomes.

methodsA convenience sample of 33 children with kidney transplant (age ≤ 18 years) who had been prescribed mycophenolate for at least 3 months were recruited from participating outpatient clinics in the UK and Jordan. Medication adherence was determined via self-report questionnaires, medication refill data from dispensing records, and via mycophenolic acid concentrations in plasma and DBS samples obtained from children during a clinic visit.

resultsThrough triangulation of results from the different methodological approaches a total of 12 children (36.4%) were deemed to be nonadherent with their prescribed mycophenolate treatment. Logistic regression analysis indicated that nonadherence was significantly associated with the presence of mycophenolate side effects. Poor adherence was positively linked to measures of poor clinical outcomes (hospitalisation and the need for kidney biopsy).

conclusionsDespite the imperative regarding medication adherence to help prevent organ rejection, a significant proportion of children are not fully adherent with their therapy. Side-effects appear to be an important factor leading to nonadherence. Measurement of mycophenolate in DBS samples, coupled with the use of population pharmacokinetics modelling, was a convenient direct approach to assessing adherence in children with kidney transplant and has the potential to be introduced into routine practice.

Indexed as

Kidney TransplantationMedication AdherenceAdolescentChildDried Blood Spot TestingFemaleHumansImmunosuppressive AgentsMaleModels, BiologicalMycophenolic AcidSelf ReportSurveys and QuestionnairesImmunosuppressive AgentsMycophenolic Acidadherencedried blood spotkidney transplantmycophenolic acid

Identifiers

PMID30845359
PMCPMC6595357
OpenAlexW2921969212

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.